Centro De Estudios en Infectología Pediátrica

What Centro De Estudios en Infectología Pediátrica does

Centro De Estudios en Infectología Pediátrica (CEIP) is a Colombia-based clinical research organization founded in 1998 and headquartered in Cali. The company operates as a specialized clinical research center focused on pediatric infectious diseases, conducting two core service lines: (1) clinical trials evaluating the efficacy and safety of clinical health interventions, and (2) observational studies examining epidemiological relationships and their impact on health without direct clinical intervention on participants. CEIP also provides clinical trial participant recruitment services, drawing on more than 25 years of recruitment experience. Its customer base is bifurcated between study participants (individuals recruited into trials) and sponsors (organizations — typically pharmaceutical or biotechnology — seeking to run clinical studies in Latin America). Tertiary stakeholders include academic and partner institutions engaging through CEIP's Academic Research Department.

The company's product surface extends beyond trial execution to include educational and convening functions, such as disease-focused publications (e.g., content on dengue fever covering DENV serotypes and Aedes transmission) and the biennial International Congress of Pediatric Infectology. The XVII Congress was held in December 2022 at the Marriott Cali, and the XVIII Congress was scheduled for July 31 – August 2, 2024, at the Intercontinental Cali Hotel, with endorsement from SLIPE (Sociedad Latinoamericana de Infectología Pediátrica) and ACIN (Asociación Colombiana de Infectología). The organization markets itself as a regional specialist and reference center for communicable disease clinical research in Latin America, distributing through its website, social channels (Facebook, Twitter), congress events, and direct outreach to sponsors and academic centers.

CEIP operates as a privately held entity under the legal name CEIP (Centro de Estudios en Infectología Pediátrica) SAS. Pricing and revenue mechanics are not publicly disclosed; engagement is transacted through direct relationships with sponsors and participants rather than published rate cards. Headcount is reported at 51–100 employees. No parent company, institutional investors, funding rounds, M&A activity, or external capital events are referenced in the available data, leaving ownership and capitalization as undisclosed data gaps. The organization appears to be operating in a steady state, with recurring congress cadence, ongoing trial activity, and an active hiring portal as the principal observed markers of organizational tempo.

Name

Centro De Estudios en Infectología Pediátrica

Legal name

CEIP (Centro de Estudios en Infectología Pediátrica)

Website

https://ceiponline.org

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

11–50 employees

Short description

Centro De Estudios en Infectología Pediátrica (CEIP) is a privately held clinical research center founded in 1998 in Cali, Colombia, specializing in pediatric infectious disease clinical trials and observational studies across Latin America. It serves pharmaceutical sponsors and study participants with over 25 years of recruitment experience.

Ownership category

akta.pro rank

Product category

Clinical Research Services

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical CROs (Phase I–IV) (HLAGAAAA)

akta.pro secondary industry

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)

Keywords

• Pediatric clinical trials
• Infectious disease research
• Observational studies
• Clinical trial recruitment
• Vaccinology research

Headquarters

HQ city

Cali

HQ country

Colombia

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Distribution channels3 records

Marketing channels4 records

Core offering

CEIP is a clinical research center that designs and conducts clinical trials and observational studies in pediatric infectious diseases. It evaluates the efficacy and safety of clinical health interventions for global implementation and studies epidemiological relationships without direct clinical intervention. It also provides experienced participant recruitment services for sponsors and organizes a biennial International Congress of Pediatric Infectology.

Product overview

CEIP (Centro de Estudios en Infectología Pediátrica) is a clinical research center specializing in pediatric infectious diseases, operating primarily in Latin America. The organization offers two core service lines: (1) Clinical Trials for evaluating efficacy and safety of health interventions, and (2) Observational Studies for epidemiological research without direct clinical intervention. Supporting these core offerings are participant recruitment services with over 25 years of experience, educational content on diseases like dengue, and the biennial International Congress of Pediatric Infectology co-endorsed by SLIPE and ACIN.

Differentiator

Problem solved

Functional benefit

Products and services

• Clinical Trials (Ensayos Clínicos) Conducting clinical trials in pediatric infectious diseases to evaluate the efficacy and safety of clinical health interventions, intended for clinical trial sponsors and global implementation.
• Observational Studies (Estudios Observacionales) Epidemiological observational studies that investigate relationships and their impact on health without performing a direct clinical intervention on the participant, for sponsors and partner institutions.
• Participant Recruitment Services Clinical trial participant recruitment services backed by more than 25 years of experience, intended for sponsors seeking to strengthen and accelerate research processes.

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Two partnerships are on record, tiered core.

• SLIPE (Sociedad Latinoamericana de Infectología Pediátrica)coreStrategic or Co-development Partner · 1 January 2024SLIPE (Latin American Society of Pediatric Infectology) provides endorsement for CEIP's XVIII International Congress of Pediatric Infectology 2024, representing a key strategic partnership for academic collaboration in the Latin American region.
• ACIN (Asociación Colombiana de Infectología)coreStrategic or Co-development Partner · 1 January 2024ACIN (Colombian Association of Infectology) provides endorsement for CEIP's XVIII International Congress of Pediatric Infectology 2024, representing a key strategic partnership for professional collaboration in Colombia.

Scale indicators3 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Syneos Health: Biopharma solutions organization offering clinical development and commercialization services with Latin America site coverage. Comparable as a CRO serving sponsors running regional infectious disease and vaccine trials.
• Medpace: Mid-to-large global CRO with growing Latin America operations, focused on Phase II–IV clinical trials across multiple therapeutic areas. Comparable as a clinical trial execution partner for sponsors.
• Parexel: Global CRO with established Latin America operations across Phase II–IV trials, including infectious disease and vaccine programs. Directly comparable service portfolio for pharma/biotech sponsors.
• ICON plc: Global CRO with substantial Latin America site network conducting Phase I–IV clinical trials across therapeutic areas including infectious disease. Directly comparable in core clinical trial execution services targeting pharma sponsors.
• PPD (Thermo Fisher Scientific): Global CRO (now part of Thermo Fisher) with extensive Latin America footprint, executing clinical trials across all phases and therapeutic areas. Direct peer for sponsors seeking regional site networks.
• Worldwide Clinical Trials: Global mid-sized CRO with Phase II–IV capabilities and Latin America presence, including experience in infectious disease and vaccine studies. Direct peer for regional clinical trial outsourcing.
• IQVIA: Largest global CRO with deep Latin America presence, offering full-service clinical trial execution, site management, and real-world evidence. Competes head-to-head for multi-country pediatric and infectious disease trials.

Regional players

• Fundación Cardiovascular de Colombia (FCV): Colombian specialty research and care institution running clinical trials from a regional hub. Comparable as a Colombia-based specialty clinical research organization serving pharma sponsors.
• Hospital de Pediatría Garrahan: Argentina's leading pediatric hospital, operating a major clinical research unit conducting pediatric trials across Latin America. Comparable as a regional pediatric-focused clinical research center serving pharma sponsors.

Broad incumbents

• St. Jude Children's Research Hospital: World-leading pediatric research institution running large-scale clinical trials in pediatric infectious diseases and oncology. Comparable as a high-credibility pediatric research brand; not a direct commercial CRO but shapes sponsor expectations for pediatric trial sites.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/ceiponline
• Facebookfacebook.com/CEIPonline

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Centro De Estudios en Infectología Pediátrica